These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7817555)

  • 1. Monoclonal antibody imaging of colorectal and ovarian cancer.
    Haseman MK
    West J Med; 1994 Oct; 161(4):412. PubMed ID: 7817555
    [No Abstract]   [Full Text] [Related]  

  • 2. Multicenter clinical trial of 111In-CYT-103 in patients with ovarian cancer.
    Gallup DG
    Targeted Diagn Ther; 1992; 6():111-24. PubMed ID: 1576342
    [No Abstract]   [Full Text] [Related]  

  • 3. Oncoscint for detection of disseminated colorectal and ovarian cancer.
    Med Lett Drugs Ther; 1993 Jun; 35(898):52-3. PubMed ID: 8497207
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunoscintigraphy with radionuclide-labeled monoclonal antibodies for tumor diagnosis and in benign diseases].
    Baum RP; Hertel A; Hör G
    Immun Infekt; 1989 Feb; 17(1):22-4. PubMed ID: 2647623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [REGAJ diagnosis of recurrence of ovarian cancer].
    Paterok EM; Jäger W; Feistel H; Lang N; Wolf F
    Gynakol Rundsch; 1989; 29 Suppl 2():360-3. PubMed ID: 2613050
    [No Abstract]   [Full Text] [Related]  

  • 6. OncoScint image atlas.
    Maguire RT
    Targeted Diagn Ther; 1992; 6():141-75. PubMed ID: 1576344
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoscintigraphy with indium-111 labeled monoclonal antibodies: the importance of a good display method.
    Liehn JC; Hannequin P; Nasca S; Lebrun D; Fernandez-Valoni A; Valeyre J
    Clin Nucl Med; 1989 Mar; 14(3):187-91. PubMed ID: 2736845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of colorectal cancer using an 111-indium labelled monoclonal antibody.
    Young H; Davidson B
    Radiogr Today; 1989 Nov; 55(630):10-1. PubMed ID: 2619909
    [No Abstract]   [Full Text] [Related]  

  • 9. The implications of patient antibody response for the clinical usefulness of immunoscintigraphy.
    Perkins AC; Pimm MV; Powell MC
    Nucl Med Commun; 1988 Apr; 9(4):273-82. PubMed ID: 3399224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.
    Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP
    Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic evaluation of 111In and 99mTc radiolabelled monoclonal antibodies in ovarian and colorectal cancer: correlations with surgery.
    Granowska M; Mather SJ; Britton KE
    Int J Rad Appl Instrum B; 1991; 18(4):413-24. PubMed ID: 1864730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunoscintigraphy of a colorectal tumor recurrence using a 99mTc-labeled anti-CEA-antibody].
    Rilinger N; Niemann H; Halbfass HJ
    Rontgenpraxis; 1989 Jul; 42(7):245-7. PubMed ID: 2756446
    [No Abstract]   [Full Text] [Related]  

  • 13. Site of mistletoe injection observed on In-111 OncoScint imaging.
    Choe W
    Clin Nucl Med; 1997 Feb; 22(2):127. PubMed ID: 9031776
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical immunoscintigraphy of recurrent ovarian cancer with indium 111-labeled B72.3 monoclonal antibody.
    Krag DN; Ford P; Smith L; Taylor M; Schneider PD; Bushberg JT; Goodnight JE
    Arch Surg; 1993 Jul; 128(7):819-23. PubMed ID: 8317965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OncoScint CR103 imaging in the surgical management of patients with colorectal cancer.
    Doerr RJ; Abdel-Nabi HH
    Targeted Diagn Ther; 1992; 6():89-109. PubMed ID: 1576352
    [No Abstract]   [Full Text] [Related]  

  • 16. [Methodology and clinical usefulness of radioimmunoimaging using radiolabeled monoclonal antibodies].
    Endo K; Watanabe N
    Nihon Rinsho; 1996 Jun; 54(6):1604-9. PubMed ID: 8691616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunolocalization of pelvic recurrences from rectosigmoid cancer employing 111In anti-CEA F(ab')2.
    Aprile C; Prati U; Saponaro R; Roveda L; Carena M; Gastaldo L
    Int J Rad Appl Instrum B; 1991; 18(1):51-2. PubMed ID: 2010306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-111 monoclonal antibody immunoscintigraphy of colorectal cancer.
    Lamki LM; Patt YZ; Murray JL
    Cancer Treat Res; 1990; 51():293-312. PubMed ID: 1977451
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunoscintigraphy in oncology exemplified by ovarian cancer].
    Pateisky N
    Gynakol Rundsch; 1989; 29 Suppl 3():40-3. PubMed ID: 2696699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 111In-CYT-103 immunoscintigraphy in ovarian cancer.
    Cannistra SA
    Gynecol Oncol; 1993 Nov; 51(2):292-4. PubMed ID: 8276314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.